Cargando…
A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery
The aim of this study was to determine the effect of oclacitinib (Apoquel) on development of surgical site infections in canines following clean orthopedic stifle surgery. Medical records of dogs undergoing unilateral, clean orthopedic stifle procedures were retrospectively examined for development...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411735/ https://www.ncbi.nlm.nih.gov/pubmed/37556416 http://dx.doi.org/10.1371/journal.pone.0289827 |
_version_ | 1785086733193314304 |
---|---|
author | Motz, Alyssa K. St. Germaine, Lindsay L. Hoffmann, Daniel E. Sung, Jed |
author_facet | Motz, Alyssa K. St. Germaine, Lindsay L. Hoffmann, Daniel E. Sung, Jed |
author_sort | Motz, Alyssa K. |
collection | PubMed |
description | The aim of this study was to determine the effect of oclacitinib (Apoquel) on development of surgical site infections in canines following clean orthopedic stifle surgery. Medical records of dogs undergoing unilateral, clean orthopedic stifle procedures were retrospectively examined for development of post-operative surgical site infections. Data collected for statistical analysis included age, sex, body weight, current medications, anesthesia and surgery times, white blood cell count, and neutrophil count. Surgical site infections were identified in 8.7% (34/390) of stifle procedures– 8.0% (29/364) in dogs not treated with oclacitinib and 19.2% (5/26) in dogs treated with oclacitinib (p = 0.053). There was a significant difference in development of surgical site infection in dogs with longer anesthesia times (p = 0.003) and higher body weights (p = 0.037). Dogs being treated with oclacitinib at the time of clean, orthopedic stifle surgery did not have a significantly higher incidence of surgical site infections. However, client education regarding risk of infection and increased patient monitoring post-operatively are recommended, especially in patients with increased body weight or longer anesthetic times. |
format | Online Article Text |
id | pubmed-10411735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-104117352023-08-10 A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery Motz, Alyssa K. St. Germaine, Lindsay L. Hoffmann, Daniel E. Sung, Jed PLoS One Research Article The aim of this study was to determine the effect of oclacitinib (Apoquel) on development of surgical site infections in canines following clean orthopedic stifle surgery. Medical records of dogs undergoing unilateral, clean orthopedic stifle procedures were retrospectively examined for development of post-operative surgical site infections. Data collected for statistical analysis included age, sex, body weight, current medications, anesthesia and surgery times, white blood cell count, and neutrophil count. Surgical site infections were identified in 8.7% (34/390) of stifle procedures– 8.0% (29/364) in dogs not treated with oclacitinib and 19.2% (5/26) in dogs treated with oclacitinib (p = 0.053). There was a significant difference in development of surgical site infection in dogs with longer anesthesia times (p = 0.003) and higher body weights (p = 0.037). Dogs being treated with oclacitinib at the time of clean, orthopedic stifle surgery did not have a significantly higher incidence of surgical site infections. However, client education regarding risk of infection and increased patient monitoring post-operatively are recommended, especially in patients with increased body weight or longer anesthetic times. Public Library of Science 2023-08-09 /pmc/articles/PMC10411735/ /pubmed/37556416 http://dx.doi.org/10.1371/journal.pone.0289827 Text en © 2023 Motz et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Motz, Alyssa K. St. Germaine, Lindsay L. Hoffmann, Daniel E. Sung, Jed A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title | A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title_full | A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title_fullStr | A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title_full_unstemmed | A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title_short | A retrospective evaluation of the effect of oclacitinib (Apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
title_sort | retrospective evaluation of the effect of oclacitinib (apoquel) administration on development of surgical site infection following clean orthopedic stifle surgery |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411735/ https://www.ncbi.nlm.nih.gov/pubmed/37556416 http://dx.doi.org/10.1371/journal.pone.0289827 |
work_keys_str_mv | AT motzalyssak aretrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT stgermainelindsayl aretrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT hoffmanndaniele aretrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT sungjed aretrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT motzalyssak retrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT stgermainelindsayl retrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT hoffmanndaniele retrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery AT sungjed retrospectiveevaluationoftheeffectofoclacitinibapoqueladministrationondevelopmentofsurgicalsiteinfectionfollowingcleanorthopedicstiflesurgery |